Catalog Number: 4LSC2533
CAS #: N/A
Related CAS #: 1195765-45-7 (unlabeled)
Name: [D9]-Dabrafenib; N-(3-(5-(2-aminopyrimidin-4-yl)-2-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide
Dabrafenib (GSK2118436) is a drug for the treatment of cancers associated with a mutated version of the gene BRAF. Dabrafenib acts as an inhibitor of the associated enzyme B-Raf, which plays a role in the regulation of cell growth.
Stable isotope labeled Dabrafenib is intended for use as an internal standard for the quantification of Dabrafenib by LC or GC-mass spectrometry.
If the number, nature and/or location of stable isotope label atoms (D, 15N, 13C) in this molecule don’t fit with your application, don’t hesitate to contact us to discuss your specific needs.
Stable isotope labeled active pharmaceutical ingredient (API), stable isotope dilution analysis, internal standard, stable isotope labeled standard (SIL), therapeutic drug monitoring (TDM), quantitative bioanalytical method validation, clinical diagnosis, LC/MS method validation, quantitative proteomics, selective reaction monitoring (SRM), multiple reaction monitoring (MRM), peptide based quantitative proteomics, custom stable isotope labeled (SIL) peptide, diagnostic breath test, clinical chemistry, diagnostic tools & biomarkers.
Enquiry about 4LSC2533 [D9]-Dabrafenib
We're ready to solve any rare chemicals sourcing or molecular design problem... Give us a shout ! Please fill out this form completely (incomplete form will not be considered).
If you don't find a product in our current offer, please don't hesitate to request a quote using our contact form.